LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 128 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $823,000 | +1.9% | 3,000 | -23.1% | 0.22% | +286.0% |
| Q2 2018 | $808,000 | -14.1% | 3,900 | -31.6% | 0.06% | -16.2% |
| Q1 2018 | $941,000 | +361.3% | 5,700 | +185.0% | 0.07% | +21.4% |
| Q3 2016 | $204,000 | +0.5% | 2,000 | +5.3% | 0.06% | -35.6% |
| Q1 2016 | $203,000 | -30.7% | 1,900 | -34.5% | 0.09% | +20.8% |
| Q2 2015 | $293,000 | +12.3% | 2,900 | -40.8% | 0.07% | -17.2% |
| Q4 2014 | $261,000 | -71.7% | 4,900 | -77.0% | 0.09% | -50.0% |
| Q3 2013 | $922,000 | – | 21,300 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |